Quantitative Susceptibility Mapping MRI in Deep-Brain Nuclei in First-Episode Psychosis

被引:1
|
作者
Saborit, Marisleydis Garcia [1 ,2 ,3 ]
Jara, Alejandro [4 ]
Munoz, Nestor [1 ,2 ,3 ]
Milovic, Carlos [5 ]
Tepper, Angeles [3 ,6 ]
Alliende, Luz Maria [6 ]
Mena, Carlos [6 ]
Iruretagoyena, Barbara [6 ]
Ramirez-Mahaluf, Juan Pablo [6 ]
Diaz, Camila [7 ]
Nachar, Ruben [7 ]
Castaneda, Carmen Paz [7 ]
Gonzalez, Alfonso [8 ,9 ]
Undurraga, Juan [8 ,10 ]
Crossley, Nicolas [2 ,3 ,6 ]
Tejos, Cristian [1 ,2 ,3 ]
机构
[1] Pontificia Univ Catolica Chile, Dept Elect Engn, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Biomed Imaging Ctr, Santiago, Chile
[3] Millennium Inst Intelligent Healthcare Engn, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Math Fac, Dept Stat, Santiago, Chile
[5] Pontificia Univ Catolica Valparaiso, Sch Elect Engn, Valparaiso, Chile
[6] Pontificia Univ Catolica Chile, Sch Med, Dept Psychiat, Santiago, Chile
[7] Inst Psiquiatr Dr J Horwitz Barak, Pharmacovigilance, Santiago, Chile
[8] Inst Psiquiatr Dr J Horwitz Barak, Early Intervent Program, Santiago, Chile
[9] Univ Finis Terrae, Sch Med, Santiago, Chile
[10] Clin Alemana Univ Desarrollo, Fac Med, Dept Neurol & Psychiat, Santiago, Chile
关键词
QSM; magnetic susceptibility; dopamine; neuromelanin; R2*rates; BASAL GANGLIA; CONTRAST MECHANISMS; LONGITUDINAL DATA; SUBSTANTIA-NIGRA; IRON; DOPAMINE; NEUROMELANIN; DISEASE; RECEPTORS; REMOVAL;
D O I
10.1093/schbul/sbad041
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Psychosis is related to neurochemical changes in deep-brain nuclei, particularly suggesting dopamine dysfunctions. We used an magnetic resonance imaging-based technique called quantitative susceptibility mapping (QSM) to study these regions in psychosis. QSM quantifies magnetic susceptibility in the brain, which is associated with iron concentrations. Since iron is a cofactor in dopamine pathways and co-localizes with inhibitory neurons, differences in QSM could reflect changes in these processes. Methods We scanned 83 patients with first-episode psychosis and 64 healthy subjects. We reassessed 22 patients and 21 control subjects after 3 months. Mean susceptibility was measured in 6 deep-brain nuclei. Using linear mixed models, we analyzed the effect of case-control differences, region, age, gender, volume, framewise displacement (FD), treatment duration, dose, laterality, session, and psychotic symptoms on QSM. Results Patients showed a significant susceptibility reduction in the putamen and globus pallidus externa (GPe). Patients also showed a significant R2* reduction in GPe. Age, gender, FD, session, group, and region are significant predictor variables for QSM. Dose, treatment duration, and volume were not predictor variables of QSM. Conclusions Reduction in QSM and R2* suggests a decreased iron concentration in the GPe of patients. Susceptibility reduction in putamen cannot be associated with iron changes. Since changes observed in putamen and GPe were not associated with symptoms, dose, and treatment duration, we hypothesize that susceptibility may be a trait marker rather than a state marker, but this must be verified with long-term studies.
引用
收藏
页码:1355 / 1363
页数:9
相关论文
共 50 条
  • [1] Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping
    Xu, Man
    Guo, Yihao
    Cheng, Junying
    Xue, Kangkang
    Yang, Meng
    Song, Xueqin
    Feng, Yanqiu
    Cheng, Jingliang
    NEUROIMAGE-CLINICAL, 2021, 31
  • [2] Brain imaging of first-episode psychosis
    Jardri, R.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2013, 39 : S93 - S98
  • [3] Incidental findings on brain MRI in patients with first-episode and chronic psychosis
    Bellani, Marcella
    Perlini, Cinzia
    Zovetti, Niccol
    Rossetti, Maria Gloria
    Alessandrini, Franco
    Barillari, Marco
    Ricciardi, Giuseppe Kenneth
    Konze, Angela
    Sberna, Maurizio
    Zoccatelli, Giada
    Lasalvia, Antonio
    Miceli, Maurizio
    Neri, Giovanni
    Torresani, Stefano
    Mazzi, Fausto
    Scocco, Paolo
    'Agostino, Armando
    Imbesi, Massimiliano
    Veronese, Angela
    Ruggeri, Mirella
    Brambilla, Paolo
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2022, 326
  • [4] FUNCTIONAL BRAIN-MAPPING OF COMPLEX HALLUCINATIONS IN FIRST-EPISODE PSYCHOSIS
    Jardri, Renaud
    Pins, Dephine
    Thomas, Pierre
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 240 - 240
  • [5] Beyond the AJR: Should Patients With First-Episode Psychosis Undergo Brain MRI?
    Tanabe, Jody
    Tregellas, Jason R.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2024, 222 (06) : e2330338
  • [6] Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study
    Kasai, K
    McCarley, RW
    Salisbury, DF
    Onitsuka, T
    Demeo, S
    Yurgelun-Todd, D
    Kikinis, R
    Jolesz, FA
    Shenton, ME
    SCHIZOPHRENIA RESEARCH, 2004, 71 (01) : 65 - 76
  • [7] First-Episode Psychosis
    Iqbal, Syed
    McDeavitt, Kathleen
    Blassingame, Jonathan Curtis
    Isa, Samya Anam
    Markan, Arushi
    Nazario, Michelle
    Shah, Asim A.
    PSYCHIATRIC ANNALS, 2025, 55 (01) : e4 - e7
  • [8] First-episode psychosis
    McGorry, PD
    ACTA PSYCHIATRICA SCANDINAVICA, 2000, 101 (02) : 172 - 172
  • [9] Obesity, dyslipidemia and brain age in first-episode psychosis
    Kolenic, Marian
    Franke, Katja
    Hlinka, Jaroslav
    Matejka, Martin
    Capkova, Jana
    Pausova, Zdenka
    Uher, Rudolf
    Alda, Martin
    Spaniel, Filip
    Hajek, Tomas
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 99 : 151 - 158
  • [10] Brain derived neurotropic factor in first-episode psychosis
    Buckley, Peter F.
    Pillai, Anilkumar
    Evans, Denise
    Stirewalt, Edna
    Mahadik, Sahebarao
    SCHIZOPHRENIA RESEARCH, 2007, 91 (1-3) : 1 - 5